WC
RXDX

Wexford Capital’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Wexford Capital’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,506
Closed -$496K – 241
2022
Q4 		$496K Buy
+4,506
New +$496K 0.1% 79